Frontage Laboratories, Inc (1521.HK), a US-based global Contract Research Organisation (CRO), announced on Wednesday that it is opening a custom-built laboratory in Hayward California.

The facility covers a 19,000 square foot area and is designed by Biologics Services Department specifically to support the local Bay Area biotech and pharmaceutical community, with services including exploratory and GLP-compliant Ligand Binding Assay (LBA) services, supporting pharmacokinetics (PK), immunogenicity (ADA), and biomarker analysis for protein therapeutics. In addition, the new laboratory is intended to support the company's Bioanalytical Services Department in providing R&D and GLP compliant, quantitative mass spectrometry services to biotech and pharmaceutical industries, including all preclinical and clinical PK/TK/DDI/BA/BE, protein binding and biomarker services.

Dr Song Li, Frontage chairman and CEO, said, 'We are pleased to open this brand-new facility in Hayward to better serve our clients' development needs. We are continuing to invest in new technology platforms while providing top-tier customer service. We grateful to the clients that have fuelled the growth of Frontage and who were integral to our decision to invest in this expansion.'